Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1995
03/08/1995EP0641334A1 Novel taxane derivatives, their preparation and compositions containing same
03/08/1995EP0641331A1 Chiral intermediates for the preparation of antidiabetics thiazoles
03/08/1995EP0641330A1 Gaba and l-glutamic acid analogs for antiseizure treatment
03/08/1995EP0641329A1 Compounds having angiotensine ii antagonistic activity
03/08/1995EP0641328A1 Bridged aza-bicyclic derivatives as substance p antagonists
03/08/1995EP0641327A1 Novel alpha-mannosidase inhibitors
03/08/1995EP0641326A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
03/08/1995EP0641325A1 Retroviral protease inhibitors
03/08/1995EP0641324A1 Tetrahydro and perhydro isoquinolin derivatives and therapeutic agents containing them
03/08/1995EP0641320A1 New centrally acting substituted phenylazacycloalkanes
03/08/1995EP0641319A1 N- N'-(5-AMINO-4-HYDROXY-ACYLOYL)-$g(a)-AMINOACYLOYL] SUBSTITUTED HETEROCYCLES AND THEIR USE AS ANTIVIRAL AGENTS
03/08/1995EP0641312A1 Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists
03/08/1995EP0641306A1 Carbocyclic and heterocyclic hiv protease inhibitors
03/08/1995EP0641302A1 Alcohols as potassium channel openers and in treatment of urinary incontinence
03/08/1995EP0641236A1 A method for coated particles in a spray-drying plant.
03/08/1995EP0641218A1 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
03/08/1995EP0641217A1 Amylase-electrolyte oral rehydration method and apparatus
03/08/1995EP0641214A1 Non-bitter protein hydrolyzates
03/08/1995EP0641213A1 Use of exogeneous glycosaminoglycanes or derivatives in the treatment of thrombopenias
03/08/1995EP0641212A1 Method and reagent for inhibiting cancer development
03/08/1995EP0641211A1 INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY
03/08/1995EP0641210A1 Use of glucocorticoids for treating and preventing aids, and compositions therefor containing same
03/08/1995EP0641209A1 New 17-ester, amide, and ketone derivatives of 3-oxo-4-azasteroids as 5a-reductase inhibitors
03/08/1995EP0641208A1 4-azasteroid 5-alpha-reductase inhibitors
03/08/1995EP0641207A1 Enantiomeric cynemicin analogs, preparation and use thereof
03/08/1995EP0641206A1 Use of cotinine to alleviate tobacco withdrawal syndrome
03/08/1995EP0641205A1 17$g(a) AND 17$g(b) SUBSTITUTED ACYL 4 AZA STEROIDS
03/08/1995EP0641204A1 17-ethers and thioethers of 4-aza-steroids
03/08/1995EP0641203A1 Imidazolyl-alkenoic acids
03/08/1995EP0641202A1 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
03/08/1995EP0641201A1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
03/08/1995EP0641200A1 2-arylpropionic acid compositions and process for preparing the same
03/08/1995EP0641199A1 Solid dispersion compositions of tebufelone
03/08/1995EP0641198A1 Medicaments for the treatment of anxiety
03/08/1995EP0641197A1 Compositions in the form of films for the treatment of periodontolysis and fabrication process
03/08/1995EP0641193A1 Chemotherapeutic drug combinations
03/08/1995EP0565546B1 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
03/08/1995EP0559743B1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use
03/08/1995EP0527922B1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
03/08/1995EP0524211B1 Pharmaceutical formulation
03/08/1995EP0500851B1 Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
03/08/1995EP0466769B1 Reducing post-prandial plasma large neutral amino acid concentrations
03/08/1995EP0439555B1 Oligosaccharides having antiatherosclerotic activity
03/08/1995EP0427843B1 Specific inhibitor for retrovirus reverse transcriptase, and its application as a medicament
03/08/1995EP0290482B1 Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
03/08/1995CN1099759A 哌嗪衍生物 Piperazine derivatives
03/08/1995CN1099758A New preparation process for 6alpha, 9alpha-difluorinated steroids and new intermediates
03/08/1995CN1099756A Tetrahydropyran derivatives
03/08/1995CN1099755A Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/08/1995CN1099753A Derivatives of amino-ascorbic acid, processes for their preparation and use
03/08/1995CN1099752A Novel amidoalkyl- and imidoalkyl-piperazines
03/08/1995CN1099750A 4-oxo-azetidin-2-sulfonic-acid-amide and salt of same, preparation and application of same
03/08/1995CN1099618A Medicine containing liposome of soyabean phospholipid and preparing method
03/08/1995CN1099617A Antitussive
03/08/1995CN1099616A Levomisol liniment
03/08/1995CN1099615A Dithiazole ointment and preparing method
03/08/1995CN1099614A 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent
03/08/1995CN1099613A Method and medical agent for diagnosis and/or therapy of arthritis
03/08/1995CN1099612A Destroying or inhibiting growth of unwanted cells or tissues
03/08/1995CN1099611A Pharmaceutical composition for preventing and treating retinal diseases
03/08/1995CN1099610A Formulation for use in smokers
03/08/1995CN1027814C Method for making monoacetyl spiramycin
03/08/1995CN1027788C Method of making chewing gum for preventing decayed tooth
03/08/1995CA2130864A1 Carboxamides
03/07/1995US5395970 1-(3,4-dihydroxyphenyl)-2-(4-(4-hydroxyphenyl)butaylamino)ethanol
03/07/1995US5395957 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
03/07/1995US5395950 Production of quinic acid derivatives
03/07/1995US5395947 Platinum(II) complex and processes for preparing the same
03/07/1995US5395944 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)quinolonecarboxylic and 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)naphthyridone-carboxylic acid intermediates
03/07/1995US5395941 Optically active 1,4-hydropyridine compounds
03/07/1995US5395934 3(2H)-pyridazinone derivatives and process for the preparation thereof
03/07/1995US5395932 2,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
03/07/1995US5395850 Antitumor agents
03/07/1995US5395848 Administering anticholesterol agent to mammals; atherosclerosis
03/07/1995US5395844 Imidazole 5-position substituted angiotensin II antagonists
03/07/1995US5395843 Pyridones
03/07/1995US5395842 Inhibitors of sex steroids
03/07/1995US5395841 4-benzylpiperidines for treating phychosis
03/07/1995US5395840 Hypotensive agents; atherosclerosis
03/07/1995US5395835 Naphthalamides as central nervous system agents
03/07/1995US5395834 New benzopyran compounds
03/07/1995US5395831 Atherosclerosis and osteoporosis treatment
03/07/1995US5395830 Method of treating osteoporosis with 1α,24(R)-dihydroxy-22(E)-dehydro-vitamin D3
03/07/1995US5395829 Compositions comprising vitamin D lumisterol analog precursors
03/07/1995US5395828 Cardiovascular
03/07/1995US5395827 ω-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists of excitatory amino acid receptors
03/07/1995US5395826 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
03/07/1995US5395824 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same
03/07/1995US5395822 Use of pyruvate to prevent neuronal degeneration associated with ischemia
03/07/1995US5395627 Pharmaceutical granulate
03/07/1995US5395624 Depigmenting cosmetic and/or dermatological composition containing a di- or tri-caffeoylquinic acid, or a mixture thereof
03/07/1995US5395615 Free amine benzophenanthridine alkaloid compositions
03/07/1995US5395611 Cysteaminylphenol derivatives
03/07/1995US5395610 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
03/07/1995CA1334671C Mitomycin phosphate derivatives
03/07/1995CA1334669C N-substituted alkylidene-1,2,3,4-tetrahydro-9- acridinamines, a process for their preparation and their use as medicaments
03/07/1995CA1334668C 13-alkyl-11beta-phenylgonanes
03/07/1995CA1334656C Esterified oligosaccharides having uronic acid and hexosamine residues
03/07/1995CA1334649C Chemical splinter removal
03/07/1995CA1334648C Onset-hastened and enhanced analgesic containing ketoprofen
1 ... 7037 7038 7039 7040 7041 7042 7043 7044 7045 7046 7047 7048 7049 7050 7051 7052 7053 7054 7055 7056 7057 ... 7860